Therefore, our study presents novel insights into the therapeutic potential of BF by highlighting their unexplored interaction with ANXA1, thus contributing to a deeper understanding of the molecular mechanisms underlying breast cancer progression. The gene discussed is ANXA1; the disease is breast carcinoma.